Skip to main content
. 2021 Apr 16;5:32. doi: 10.1038/s41698-021-00170-7

Table 1.

Results of the gene mutation analysis.

Results of EGFR mutation diagnostic tests In house NGS (Amplicon Seq)
Cobas® Scorpion-ARMS
JFCR-226 JFCR-065 PC9 A431 JFCR-226 JFCR-065 PC9 A431 JFCR-226
EGFR exon18 G719X × × × × × × × × EGFR: c2239_2240TT > CC (p.L747P)
EGFR exon19 deletions × ×
EGFR exon20 S768I × × × × × × × ×
EGFR exon20 Insertions × × × × × × × ×
EGFR exon20 T790M × × × × × × × ×
EGFR exon21 L858R × × × × × × × ×
EGFR exon21 L861Q × × × × × × × ×

〇; positive, ×; negative.

PC9; EGFR exon19 deletion positive NSCLC cell line.

JFCR-065; EGFR exon19 deletion positive NSCLC cell line.

A431; EGFR wild (EGFR gene amplified).

(a) Comparison of LCC226, LCC065 (patient-derived cells expressing EGFR 19 deletions), PC9 (cells expressing EGFR 19 deletions), and A431 (human squamous carcinoma cells harboring wildtype EGFR gene amplification) by Cobas® and Scorpion-ARMS® EGFR gene mutation analysis results and LCC226 NGS analysis results.